KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -97.8% | 1,000 | -96.0% | 0.00% | – |
| Q1 2022 | $182,000 | -9.9% | 24,729 | -21.6% | 0.00% | – |
| Q4 2021 | $202,000 | +242.4% | 31,543 | +450.9% | 0.00% | – |
| Q2 2021 | $59,000 | -24.4% | 5,726 | -23.2% | 0.00% | – |
| Q1 2021 | $78,000 | -83.6% | 7,456 | -75.8% | 0.00% | -100.0% |
| Q4 2020 | $477,000 | +736.8% | 30,846 | +936.8% | 0.00% | – |
| Q1 2020 | $57,000 | – | 2,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |